• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
INO

INO

Inovio Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.14

-0.07 (-5.79%)

Rating:C-

Company Profile

CEO

Jacqueline E. Shea

IPO Date

1998-12-08

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.21

Prev. Close

$1.21

Day Low

$1.13

Day High

$1.22

52W Low

$1.03

52W High

$2.98

Market Cap

$0.06B

Volume

1.76M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

56.0%

Avg Negative

14.1%

Avg Neutral

29.8%

News Feed

INOVIO to Report Second Quarter 2021 Financial Results on August 9, 2021

PRNewsWire·7/26/2021·↓ negative

Is Inovio Pharmaceuticals Primed For a Comeback?

The Motley Fool·7/22/2021·↓ negative

Bear of the Day: Inovio Pharmaceuticals (INO)

Zacks Investment Research·7/12/2021·↓ negative

Here's Why Inovio Pharmaceuticals Soared 23% In June

The Motley Fool·7/8/2021·↑ positive

Inovio Has 4 Sources Of Potential Value

Seeking Alpha·6/22/2021·↑ positive

Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships

InvestorPlace·6/21/2021·↑ positive

Why Inovio Stock Is Sinking Today

The Motley Fool·6/10/2021·↑ positive

Why Inovio Stock Looks Ready To Break Out, Make Bullish Reversal

Benzinga·6/9/2021·↑ positive

INO Stock: 2 Big Reasons Inovio Pharmaceuticals Is Shooting Higher Today

InvestorPlace·6/9/2021·↑ positive

Inovio, Advaccine to Share $100M in Cost for Late-Stage COVID-19 Vaccine Trial

Benzinga·6/8/2021·↑ positive